Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Levemir
Pharma
Novo Nordisk attracts lawmakers' ire for Levemir insulin pull
Novo Nordisk is facing lawmaker pushback over its decision to discontinue its insulin product Levemir, which was due for a steep discount in January.
Fraiser Kansteiner
Apr 18, 2024 10:40am
Bayer, Novo separately opt to discontinue their Aliqopa, Levemir
Nov 9, 2023 9:10am
Novo Nordisk answers government call to reduce US insulin prices
Mar 14, 2023 11:11am
Novo pulls insulin samples after Texas storm idles refrigerators
May 7, 2021 6:02pm
Celgene, Roche and Novo increased prices on some top sellers
Jul 12, 2018 11:40am
Novo CEO touts sales growth in midst of price cuts
Aug 9, 2017 12:26pm
